Core Viewpoint - Kingsoft Cloud Holdings Limited (KC) has seen a 14.3% increase in share price over the past four weeks, closing at $14.4, with a potential upside of 26.1% based on Wall Street analysts' mean price target of $18.16 [1] Price Targets - The average of seven short-term price targets ranges from a low of $15.60 to a high of $20.00, with a standard deviation of $1.55, indicating a potential increase of 8.3% to 38.9% from the current price level [2] Analyst Sentiment - Analysts show a strong consensus that KC will report better earnings than previously estimated, which is a positive indicator for potential stock upside [4][11] - The Zacks Consensus Estimate for the current year has increased by 0.7% due to one upward revision in earnings estimates over the last 30 days [12] Zacks Rank - KC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential for near-term upside [13] Caution on Price Targets - While price targets are commonly referenced, they can mislead investors, as empirical research indicates that they rarely predict actual stock price movements accurately [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8][9]

Core Viewpoint - Franklin Covey (FC) shares have increased by 4.4% recently, closing at $14.23, with analysts suggesting a potential upside of 99.1% based on a mean price target of $28.33 [1] Price Targets - The average price target for FC ranges from a low of $22.00 to a high of $38.00, with a standard deviation of $8.5, indicating variability in analyst estimates [2] - The lowest estimate suggests a 54.6% increase from the current price, while the highest estimate indicates a potential upside of 167% [2] Analyst Consensus - There is strong agreement among analysts regarding FC's ability to report better earnings than previously predicted, which supports the view of potential upside [4] - A positive trend in earnings estimate revisions has been shown to correlate with stock price movements, indicating a potential for growth [11] Earnings Estimates - Over the past 30 days, one earnings estimate for FC has increased, with no negative revisions, leading to a 0.4% rise in the Zacks Consensus Estimate [12] - FC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting strong potential for upside [13] Price Movement Guidance - While consensus price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [14]

Group 1 - Intellicheck Mobilisa, Inc. (IDN) closed at $5.54, with a 13.5% gain over the past four weeks, and a mean price target of $7.88 suggests a 42.2% upside potential [1] - The mean estimate includes four short-term price targets with a standard deviation of $0.75, indicating variability; the lowest estimate of $7.00 shows a 26.4% increase, while the highest target of $8.50 indicates a 53.4% increase [2] - Analysts agree that IDN is expected to report better earnings than previously estimated, which strengthens the view of potential upside [4] Group 2 - The Zacks Consensus Estimate for the current year has increased by 26.3% over the last 30 days, with one estimate moving higher and no negative revisions [12] - IDN holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting the extent of gains, they can indicate the direction of price movement [14]

Core Viewpoint - Tactile Systems Technology (TCMD) shows potential for significant upside, with a mean price target of $38 indicating a 41.1% increase from its current price of $26.93 [1] Price Targets and Analyst Consensus - The average price target for TCMD ranges from a low of $32.00 to a high of $42.00, with a standard deviation of $4.32, suggesting a consensus among analysts [2] - The lowest estimate indicates an 18.8% increase, while the highest suggests a 56% upside [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Optimism - Analysts have shown increasing optimism about TCMD's earnings prospects, with a strong agreement in revising EPS estimates higher [11] - The Zacks Consensus Estimate for the current year has increased by 17.6% over the past month, with three estimates going higher and no negative revisions [12] - TCMD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Solely relying on price targets for investment decisions may not be wise, as analysts' ability to set accurate targets has been questioned [3][7] - Price targets should be treated with skepticism, as they can often mislead investors [10]

Core Viewpoint - Shares of MSTR have increased by 13.4% over the past four weeks, closing at $146.44, with a mean price target of $395.93 indicating a potential upside of 170.4% [1] Price Targets - The average of 14 short-term price targets ranges from a low of $185.00 to a high of $705.00, with a standard deviation of $172.27, suggesting a potential increase of 26.3% to 381.4% from the current price [2] - A low standard deviation indicates a greater agreement among analysts regarding price estimates, which can be a useful metric for investors [2][9] Analyst Sentiment - Analysts are increasingly optimistic about MSTR's earnings prospects, as evidenced by a strong consensus in revising EPS estimates higher, which correlates with potential stock price movements [4][11] - Over the last 30 days, two earnings estimates have been revised upward, leading to a Zacks Consensus Estimate increase of 112.2% [12] Zacks Rank - MSTR holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Caution on Price Targets - While price targets are a common metric, relying solely on them for investment decisions may not be prudent due to historical inaccuracies in predicting actual stock price movements [3][7][10]

Core Viewpoint - Shares of Credo Technology Group Holding Ltd. (CRDO) have increased by 5.8% in the past four weeks, closing at $102.54, with a mean price target of $200 indicating a potential upside of 95.1% [1] Price Targets and Analyst Consensus - The average of 13 short-term price targets ranges from a low of $125.00 to a high of $260.00, with a standard deviation of $37.36, suggesting a potential increase of 21.9% to 153.6% from the current price [2] - A low standard deviation indicates a strong agreement among analysts regarding the price targets, which can be a useful metric for investors [2][9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about CRDO's earnings prospects, with a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 19.2%, with five estimates moving higher and no negative revisions [12] Zacks Rank and Investment Potential - CRDO holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside in the near term [13] Caution on Price Targets - While the consensus price target is a commonly referenced metric, relying solely on it for investment decisions may not be prudent due to historical inaccuracies in price predictions by analysts [3][10]

Core Insights - Investors are advised to be cautious when relying on Wall Street's price targets for Tesla shares, as these targets may not accurately reflect the company's true value [1] Group 1: Company Analysis - Tesla's stock price targets set by analysts may not align with the company's actual performance and market conditions [1] - The volatility of Tesla's stock makes it essential for investors to conduct their own research rather than solely depending on external price predictions [1] Group 2: Industry Context - The electric vehicle (EV) market is rapidly evolving, and external factors can significantly impact Tesla's valuation [1] - Analysts' price targets may be influenced by market sentiment rather than fundamental analysis, leading to potential misjudgments in investment decisions [1]

Group 1 - QuinStreet (QNST) shares have increased by 2.5% over the past four weeks, closing at $11.73, with a mean price target of $20.25 indicating a potential upside of 72.6% [1] - The average price targets range from a low of $15.00 to a high of $26.00, with a standard deviation of $5.56, suggesting a variability in analyst estimates [2] - Analysts are optimistic about QNST's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which have increased by 35.5% over the past month [12] Group 2 - The Zacks Consensus Estimate for QNST has seen three upward revisions with no negative revisions, indicating strong analyst agreement on the company's earnings potential [12] - QNST holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of the stock's potential gain, it does suggest a positive direction for price movement [14]

Core Viewpoint - Biodesix, Inc. (BDSX) has seen a significant stock price increase of 53.1% over the past four weeks, closing at $15.75, with analysts suggesting a potential upside of 111.6% based on a mean price target of $33.33 [1] Price Targets and Analyst Consensus - The average price target for BDSX ranges from a low of $20.00 to a high of $40.00, with a standard deviation of $11.55, indicating variability in analyst estimates [2] - The lowest estimate suggests a 27% increase from the current price, while the highest estimate indicates a potential upside of 154% [2] - A low standard deviation signifies a strong agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Optimism - Analysts show strong agreement in revising earnings estimates higher for BDSX, which correlates with potential stock price increases [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 3.5%, with one estimate increasing and no negative revisions [12] - BDSX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] Caution on Price Targets - While price targets are commonly referenced, they can mislead investors, as empirical research shows they rarely indicate actual stock price movements [7] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8] - Despite the skepticism surrounding price targets, the direction implied by them can serve as a useful guide for further research [10][14]

Core Viewpoint - Senseonics Holdings (SENS) has shown a significant price increase of 14.9% over the past four weeks, with a mean price target of $18.7 indicating a potential upside of 124.5% from the current price of $8.33 [1] Price Targets and Analyst Estimates - The mean estimate consists of five short-term price targets with a standard deviation of $8.07, where the lowest estimate is $9.00 (an 8% increase) and the highest is $31.00 (a 272.2% increase) [2] - A low standard deviation among price targets suggests a strong agreement among analysts regarding the stock's price movement [9] Analyst Sentiment and Earnings Estimates - Analysts have shown increasing optimism about SENS's earnings prospects, as indicated by a positive trend in earnings estimate revisions [11] - The Zacks Consensus Estimate for the current year has increased by 4% over the past month, with one estimate rising and no negative revisions [12] - SENS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are often sought after by investors, they can be misleading and should not be the sole basis for investment decisions [3][7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]